Stereotactic Body Radiotherapy for Medically Inoperable Lung Cancer: Prospective, Single-Center Study of 108 Consecutive Patients-Reference-Cited by-同舟云学术

Stereotactic Body Radiotherapy for Medically Inoperable Lung Cancer: Prospective, Single-Center Study of 108 Consecutive Patients

Published:2012-02 Issue:2 Volume:82 Page:967-973
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Taremi Mojgan,Hope Andrew,Dahele Max,Pearson Shannon,Fung Sharon,Purdie Thomas,Brade Anthony,Cho John,Sun Alexander,Bissonnette Jean-Pierre,Bezjak Andrea

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference28 articles.

1. Incidence of local recurrence and second primary tumors in resected stage I lung cancer;Martini;J Thorac Cardiovasc Surg,1995

2. The effect of race on invasive staging and surgery in non–small-cell lung cancer;Lathan;J Clin Oncol,2006

3. Radiotherapy alone for medically inoperable stage I non–small-cell lung cancer: The Duke experience;Sibley;Int J Radiat Oncol Biol Phys,1998

4. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

5. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I NSCLC;Lagerwaard;Int J Radiat Oncol Biol Phys,2008

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and survival outcomes in octogenarians with early-stage non-small cell lung cancer from 2011 to 2020: a SEER database analysis;2024-08-26

2. Radiotherapy in the management of lung oligometastases;Cancer/Radiothérapie;2024-02

3. Hypofractionation for Lung Tumors (Primary Malignant, Secondary Malignant);Hypofractionated and Stereotactic Radiation Therapy;2024

4. Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-small Cell Lung Cancer – A Phase I Dose Escalation Trial;International Journal of Radiation Oncology*Biology*Physics;2023-12

5. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms;Pneumologie;2023-10